Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

Overcoming the Mental Battle of Metastatic Cancer

December 24th 2014, 2:51am

Article

The mental challenges of having stage 4 breast cancer are just as overwhelming as the physical ones.

Firstline Kadcyla Results Disappointing in HER2-Positive Metastatic Breast Cancer Trial

December 19th 2014, 10:50pm

Article

Two HER2-targeting regimens anchored by Kadcyla (T-DM1) failed to outperform the standard strategy of Herceptin plus chemotherapy in women newly diagnosed with advanced HER2-positive breast cancer.

Upfront Faslodex Improves Survival Over Anastrozole in Estrogen-Positive Metastatic Breast Cancer

December 17th 2014, 1:29am

Article

Faslodex (fulvestrant) improved overall survival by nearly six months compared with anastrozole as initial hormone therapy for postmenopausal women with estrogen receptor-positive advanced breast cancer, according to findings from the phase 2 FIRST trial.

Advocates Call for More Attention to Metastatic Breast Cancer

December 12th 2014, 10:52am

Article

Karen Durham never expected to be speaking on behalf of the Metastatic Breast Cancer Alliance

SABCS: Debu Tripathy Discusses PI3 Kinase Inhibitors in Breast Cancer

December 12th 2014, 1:08am

Article

Debu Tripathy, editor-in-chief of CURE magazine, reports from the San Antonio Breast Breast Cancer Symposium where a study involving the PI3 kinase inhibitor pictilisib showed interesting results.

Early Phase Study Finds PI3K Inhibitor Pictilisib Helps a Subset of Advanced Breast Cancer Patients

December 11th 2014, 9:01pm

Article

The addition of the investigational PI3K inhibitor pictilisib to the aromatase inhibitor Faslodex in patients with metastatic breast cancer yielded some intriguing findings in the FERGI study.

ASCO: Early Studies Show Promise in Treating Metastatic Breast Cancer

June 5th 2014, 8:11pm

Article

Debu Tripathy, MD, editor-in-chief of CURE magazine, shares the latest research in metastatic breast cancer, including targeted drugs being tested in early-phase studies that appear promising, including the PARP inhibitor veliparib, the CDK4/6 inhibitor palbociclib and the anti-angiogenesis drug trametinib.